HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples

Journal of Molecular Diagnostics

Volumn 17, Issue 6, 2015, Pages 729-739

  Moens, Lotte N J ^a   Falk Sörqvist, Elin ^a   Ljungström, Viktor ^a   Mattsson, Johanna ^a   Sundström, Magnus ^a   La Fleur, Linnéa ^a   Mathot, Lucy ^a   Micke, Patrick ^a   Nilsson, Mats ^a,b   Botling, Johan ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FORMALDEHYDE; PARAFFIN;

ARTICLE; ARTIFACT REDUCTION; CANCER TISSUE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA FRAGMENTATION; FALSE POSITIVE RESULT; FROZEN SECTION; GENE FREQUENCY; GENETIC VARIABILITY; HALOPLEX TARGETED RESEQUENCING; HIGH THROUGHPUT SEQUENCING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; MOLECULAR DIAGNOSIS; MUTATION RATE; MUTATIONAL ANALYSIS; NEOPLASM; NEXT GENERATION SEQUENCING; NON SMALL CELL LUNG CANCER; SEQUENCE ANALYSIS; SOMATIC MUTATION; CHEMISTRY; GENETICS; MUTATION; PROCEDURES; TISSUE FIXATION;

DNA; FORMALDEHYDE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; NEOPLASMS; PARAFFIN; PARAFFIN EMBEDDING; TISSUE FIXATION;

EID: 84943608553     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.06.009     Document Type: Article

References (41)

1. M. Meyerson, S. Gabriel, and G. Getz Advances in understanding cancer genomes through second-generation sequencing Nat Rev Genet 11 2010 685 696
2. M.R. Schweiger, M. Kerick, B. Timmermann, M.W. Albrecht, T. Borodina, D. Parkhomchuk, K. Zatloukal, and H. Lehrach Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis PLoS One 4 2009 e5548
3. N. Navin, A. Krasnitz, L. Rodgers, K. Cook, J. Meth, J. Kendall, M. Riggs, Y. Eberling, J. Troge, V. Grubor, D. Levy, P. Lundin, S. Maner, A. Zetterberg, J. Hicks, and M. Wigler Inferring tumor progression from genomic heterogeneity Genome Res 20 2010 68 80
4. A.N. Desai, and A. Jere Next-generation sequencing: ready for the clinics? Clin Genet 81 2012 503 510
5. C.E. Greer, S.L. Peterson, N.B. Kiviat, and M.M. Manos PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time Am J Clin Pathol 95 1991 117 124
6. N. Quach, M.F. Goodman, and D. Shibata In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during PCR BMC Clin Pathol 4 2004 1
7. C. Williams, F. Ponten, C. Moberg, P. Soderkvist, M. Uhlen, J. Ponten, G. Sitbon, and J. Lundeberg A high frequency of sequence alterations is due to formalin fixation of archival specimens Am J Pathol 155 1999 1467 1471
8. M. Kerick, M. Isau, B. Timmermann, H. Sultmann, R. Herwig, S. Krobitsch, G. Schaefer, I. Verdorfer, G. Bartsch, H. Klocker, H. Lehrach, and M.R. Schweiger Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity BMC Med Genomics 4 2011 68
9. D. Sie, P.J. Snijders, G.A. Meijer, M.W. Doeleman, M.I. van Moorsel, H.F. van Essen, P.P. Eijk, K. Grunberg, N.C. van Grieken, E. Thunnissen, H.M. Verheul, E.F. Smit, B. Ylstra, and D.A. Heideman Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology Cell Oncol (Dordr) 37 2014 353 361
10. K. Tuononen, S. Maki-Nevala, V.K. Sarhadi, A. Wirtanen, M. Ronty, K. Salmenkivi, J.M. Andrews, A.I. Telaranta-Keerie, S. Hannula, S. Lagstrom, P. Ellonen, A. Knuuttila, and S. Knuutila Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS Genes Chromosomes Cancer 52 2013 503 511
11. F. Belardinilli, C. Capalbo, A. Buffone, M. Petroni, V. Colicchia, S. Ferraro, M. Zani, A. Nicolussi, S. D'Inzeo, A. Coppa, I. Screpanti, A. Gulino, and G. Giannini Validation of the Ion Torrent PGM Sequencing for the prospective routine molecular diagnostic of colorectal cancer Clin Biochem 48 2015 908 910
12. V. Endris, R. Penzel, A. Warth, A. Muckenhuber, P. Schirmacher, A. Stenzinger, and W. Weichert Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing J Mol Diagn 15 2013 765 775
13. L. Zhang, L. Chen, S. Sah, G.J. Latham, R. Patel, Q. Song, H. Koeppen, R. Tam, E. Schleifman, H. Mashhedi, S. Chalasani, L. Fu, T. Sumiyoshi, R. Raja, W. Forrest, G.M. Hampton, M.R. Lackner, P. Hegde, and S. Jia Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing Oncologist 19 2014 336 343
14. S.Q. Wong, J. Li, R. Salemi, K.E. Sheppard, H. Do, R.W. Tothill, G.A. McArthur, and A. Dobrovic Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours Sci Rep 3 2013 3494
15. Z. Zheng, M. Liebers, B. Zhelyazkova, Y. Cao, D. Panditi, K.D. Lynch, J. Chen, H.E. Robinson, H.S. Shim, J. Chmielecki, W. Pao, J.A. Engelman, A.J. Iafrate, and L.P. Le Anchored multiplex PCR for targeted next-generation sequencing Nat Med 20 2014 1479 1484
16. A.G. Hadd, J. Houghton, A. Choudhary, S. Sah, L. Chen, A.C. Marko, T. Sanford, K. Buddavarapu, J. Krosting, L. Garmire, D. Wylie, R. Shinde, S. Beaudenon, E.K. Alexander, E. Mambo, A.T. Adai, and G.J. Latham Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens J Mol Diagn 15 2013 234 247
17. F. Dahl, M. Gullberg, J. Stenberg, U. Landegren, and M. Nilsson Multiplex amplification enabled by selective circularization of large sets of genomic DNA fragments Nucleic Acids Res 33 2005 e71
18. H. Johansson, M. Isaksson, E.F. Sorqvist, F. Roos, J. Stenberg, T. Sjoblom, J. Botling, P. Micke, K. Edlund, S. Fredriksson, H.G. Kultima, O. Ericsson, and M. Nilsson Targeted resequencing of candidate genes using selector probes Nucleic Acids Res 39 2011 e8
19. M. Martin Cutadapt removes adapter sequences from high-throughput sequencing reads EMBnet.Journal 17 2011 10 12
20. M. Srinivasan, D. Sedmak, and S. Jewell Effect of fixatives and tissue processing on the content and integrity of nucleic acids Am J Pathol 161 2002 1961 1971
21. B. Strauss, S. Rabkin, D. Sagher, and P. Moore The role of DNA polymerase in base substitution mutagenesis on non-instructional templates Biochimie 64 1982 829 838
22. B.S. Strauss The "A" rule revisited: polymerases as determinants of mutational specificity DNA Repair (Amst) 1 2002 125 135
23. CancerGenomeAtlasResearchNetwork Comprehensive genomic characterization of squamous cell lung cancers Nature 489 2012 519 525
24. M. Imielinski, A.H. Berger, P.S. Hammerman, B. Hernandez, T.J. Pugh, E. Hodis, and et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing Cell 150 2012 1107 1120
25. G.R. Abecasis, D. Altshuler, A. Auton, L.D. Brooks, R.M. Durbin, R.A. Gibbs, M.E. Hurles, and G.A. McVean A map of human genome variation from population-scale sequencing Nature 467 2010 1061 1073
26. M.S. Lawrence, P. Stojanov, C.H. Mermel, J.T. Robinson, L.A. Garraway, T.R. Golub, M. Meyerson, S.B. Gabriel, E.S. Lander, and G. Getz Discovery and saturation analysis of cancer genes across 21 tumour types Nature 505 2014 495 501
27. L. Agell, S. Hernandez, S. de Muga, J.A. Lorente, N. Juanpere, R. Esgueva, S. Serrano, A. Gelabert, and J. Lloreta KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations Mod Pathol 21 2008 1470 1478
28. C.L. Corless, and P.T. Spellman Tackling formalin-fixed, paraffin-embedded tumor tissue with next-generation sequencing Cancer Discov 2 2012 23 24
29. H. Do, and A. Dobrovic Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies Mol Cancer 8 2009 82
30. M. Akbari, M.D. Hansen, J. Halgunset, F. Skorpen, and H.E. Krokan Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner J Mol Diagn 7 2005 36 39
31. H. Do, S.Q. Wong, J. Li, and A. Dobrovic Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates Clin Chem 59 2013 1376 1383
32. H. Do, and A. Dobrovic Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase Oncotarget 3 2012 546 558
33. S.E. Yost, E.N. Smith, R.B. Schwab, L. Bao, H. Jung, X. Wang, E. Voest, J.P. Pierce, K. Messer, B.A. Parker, O. Harismendy, and K.A. Frazer Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens Nucleic Acids Res 40 2012 e107
34. S. Kirsch, and C.A. Klein Sequence error storms and the landscape of mutations in cancer Proc Natl Acad Sci U S A 109 2012 14289 14290
35. M.W. Schmitt, S.R. Kennedy, J.J. Salk, E.J. Fox, J.B. Hiatt, and L.A. Loeb Detection of ultra-rare mutations by next-generation sequencing Proc Natl Acad Sci U S A 109 2012 14508 14513
36. M. Gerlinger, A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, S. Begum, N.Q. McDonald, A. Butler, D. Jones, K. Raine, C. Latimer, C.R. Santos, M. Nohadani, A.C. Eklund, B. Spencer-Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P.A. Futreal, and C. Swanton Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892
37. C. Swanton Intratumor heterogeneity: evolution through space and time Cancer Res 72 2012 4875 4882
38. G.C. Nickel, J. Barnholtz-Sloan, M.P. Gould, S. McMahon, A. Cohen, M.D. Adams, K. Guda, M. Cohen, A.E. Sloan, and T. LaFramboise Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence PLoS One 7 2012 e35262
39. A. Villanueva, and J.M. Llovet Impact of intra-individual molecular heterogeneity in personalized treatment of hepatocellular carcinoma Hepatology 56 2012 2416 2419
40. S. Misale, R. Yaeger, S. Hobor, E. Scala, M. Janakiraman, D. Liska, E. Valtorta, R. Schiavo, M. Buscarino, G. Siravegna, K. Bencardino, A. Cercek, C.T. Chen, S. Veronese, C. Zanon, A. Sartore-Bianchi, M. Gambacorta, M. Gallicchio, E. Vakiani, V. Boscaro, E. Medico, M. Weiser, S. Siena, F. Di Nicolantonio, D. Solit, and A. Bardelli Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer Nature 486 2012 532 536
41. L.A. Diaz Jr., R.T. Williams, J. Wu, I. Kinde, J.R. Hecht, J. Berlin, B. Allen, I. Bozic, J.G. Reiter, M.A. Nowak, K.W. Kinzler, K.S. Oliner, and B. Vogelstein The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers Nature 486 2012 537 540